SIK3 and triple-negative breast carcinoma: It is of interest to note that (Fig 1F) triple negative breast cancer cell lines (MDA-MB-231 and BT-20) known for their high treatment resistance have shown statistically significant (p<0.05) higher expression of SIK3 compared to receptor positive cell lines (MCF-7 and AU565).